Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw ...

Lower rates of both progression of macular fibrosis and intravitreal aflibercept injections were found in those who used the ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

Respiratory Syncytial Virus (RSV) is a highly contagious respiratory illness that primarily affects infants and older adults, ...

RSV is usually contagious for three to eight days. A patient also may be contagious a day or two before experiencing symptoms ...

Sneezing, fever, chills, vomiting, coughing — it’s not just one virus wreaking havoc this winter; it’s a combination of four ...

Thousands of Oklahomans are sick with the flu. Symptoms of influenza include chills, fever, cough and body aches.

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

During cold and flu season, it can be challenging to differentiate illnesses like the common cold, flu, COVID-19, respiratory ...